New for this year, SCOPE is introducing a dedicated conference on Market Access, Reimbursement & Licensing—designed to bridge the gap between clinical development and commercial strategy. As drug developers face growing pressure to demonstrate not only safety and efficacy but also value and affordability, this conference will explore how early evidence generation, pipeline planning, payer-aligned trial design, and real-world outcomes are shaping the future of access and reimbursement. Senior leaders in market access, clinical development, clinical operations, HEOR, RWE, and commercial planning will share strategies for embedding access thinking into clinical planning—ensuring that innovation is not only approved, but also reimbursed, adopted, and sustained. Join a diverse group of experts working to align development decisions with market realities from day one.